In a 35‑year‑old male with low testosterone, low‑normal luteinizing hormone (LH), normal follicle‑stimulating hormone (FSH), fatigue, decreased libido, and 8 kg weight gain over six months, what is the likely diagnosis and appropriate evaluation and treatment?

Functional Secondary Hypogonadism with Likely Metabolic Etiology

This 35-year-old man has functional secondary (hypogonadotropic) hypogonadism, most likely driven by metabolic dysfunction related to his recent 8kg weight gain, and the first-line treatment is aggressive weight loss through caloric restriction and physical activity, not testosterone therapy 1.

Diagnosis

The hormonal pattern is diagnostic:

• Low-normal testosterone (9.80 nmol/L, just above the 8.64 threshold)
• Inappropriately low-normal LH (1.6 IU/L, below the 1.7 lower limit)
• Normal FSH (3.0 IU/L)

This constellation indicates secondary hypogonadism where the hypothalamic-pituitary axis is failing to appropriately stimulate testosterone production. The LH should be elevated in response to low testosterone, but instead it's suppressed 1, 2.

The recent 8kg weight gain is the critical clue. Obesity directly suppresses the hypothalamic-pituitary-gonadal (HPG) axis, and this patient's presentation fits the pattern of functional hypogonadism rather than organic disease 1, 3. Functional hypogonadism is potentially reversible when the underlying metabolic disturbance is corrected 1, 4.

Essential Further Evaluation

Before any treatment decisions:

1. Confirm the diagnosis with a second fasting morning (7-10 AM) total testosterone measurement 1, 5, 2

2. Calculate free testosterone using total testosterone and SHBG, as obesity lowers SHBG and may mask the true severity 1, 2

3. Screen for metabolic syndrome components: fasting glucose, HbA1c, lipid panel, blood pressure, waist circumference 1

4. Exclude secondary causes:

   • Prolactin level (to rule out prolactinoma)
   • TSH (thyroid dysfunction affects testosterone)
   • Medication review (opioids, glucocorticoids cause hypogonadism) 1, 2
   • Sleep history (obstructive sleep apnea is common with weight gain and causes hypogonadism)

5. Consider pituitary MRI only if prolactin is elevated or there are neurological symptoms suggesting a mass lesion 1

Treatment Algorithm

First-Line: Lifestyle Modification (Mandatory Initial Approach)

Weight loss is the primary treatment for obesity-associated functional hypogonadism 1, 2. The evidence is clear:

• Weight loss of ≥5% significantly increases testosterone levels and improves sexual function, libido, and physical function 2, 3
• Meta-analyses confirm that low-calorie diets reverse obesity-associated secondary hypogonadism by normalizing gonadotropins 1
• Physical exercise provides similar benefits, with effects correlating to exercise duration and weight loss 1, 3

Specific recommendations:

• Target ≥5-10% weight loss through caloric restriction (500-750 kcal/day deficit)
• Endurance exercise 150+ minutes weekly has been shown to reduce hypothalamic inflammation and improve HPG axis function 3
• Address metabolic syndrome components aggressively (if present)
• Discontinue any medications that suppress the HPG axis 1

When to Consider Testosterone Therapy

Testosterone therapy should NOT be first-line in this patient 1, 4. However, consider it in these specific scenarios:

1. After lifestyle intervention fails (3-6 months trial with inadequate symptom improvement)
2. If testosterone remains <8 nmol/L on repeat testing with persistent symptoms 1
3. As a short-term bridge (3-6 months) to help overcome physical limitations that prevent exercise and weight loss, then reassess 3, 4

Critical caveat: Testosterone therapy suppresses fertility by shutting down the HPG axis 1. If fertility is a concern now or in the future, testosterone is contraindicated. Instead, gonadotropin therapy (hCG ± FSH) would be required 1.

If Testosterone Therapy is Initiated

The 2025 EAU guidelines recommend 1:

• Choose formulation based on patient preference (transdermal gel, intramuscular injection, or oral)
• Monitor testosterone levels, hematocrit, and PSA
• Reassess symptoms at 3-6 months
• Attempt to wean off testosterone after weight loss is achieved to see if HPG axis recovers

Common Pitfalls to Avoid

1. Starting testosterone without confirming diagnosis with repeat testing - single measurements are unreliable 1, 5
2. Ignoring the weight gain as the primary driver - treating with testosterone alone without addressing obesity will provide suboptimal results 1
3. Not calculating free testosterone - total testosterone may underestimate deficiency in obesity due to low SHBG 1, 2
4. Missing secondary causes - particularly medications (opioids, steroids), sleep apnea, or prolactinoma 1, 2
5. Failing to counsel about fertility - testosterone therapy will worsen fertility 1

Prognosis

Functional hypogonadism is potentially reversible 1, 3, 4. With successful weight loss and metabolic optimization, this patient's HPG axis may normalize, testosterone levels will rise modestly (1-2 nmol/L increase expected), and symptoms should improve 1, 3. The combination of lifestyle modification plus targeted symptom management (e.g., PDE5 inhibitors for erectile dysfunction if present) is often effective without requiring testosterone 4.